Conference Coverage
Noninvasive testing in midlife flags late-onset epilepsy risk
The study could help identify at-risk individuals years before symptoms of epilepsy appear.
The study could help identify at-risk individuals years before symptoms of epilepsy appear.
The early significant seizure reduction observed in this study appears to be durable in these first two patients treated with a single...
To celebrate our 30th year in print, Neurology Reviews invited experts to look back on 30 years of progress in their subspecialty. In this...
“Increasing the attention to these inequities will, we hope, prompt changes across practices,” researchers said.
Both adults and adolescents reported benefits from the diet, which is a less strict version of a traditional ketogenic diet.
A large case-control study found a considerably higher risk of developing Parkinson’s disease among patients who had taken AEDs in comparison with...
Dementia patients who also had active seizures had shorter life expectancy and earlier decline than dementia patients who didn’t have active...
A Scandinavian study of 4.5 million births adds carbamazepine, oxcarbazepine, and topiramate to list of antiseizure drugs linked to low birth...
“We hope these results inspire epileptologists and neurologists to both recognize and screen ... adolescent patients.”
“The results suggest that racial minorities, those with a lower income, and the elderly are an appropriate target to improve health outcomes and...
Researchers have found that changes in the insulating layer around nerves and axons in the brain may explain the progression of absence seizures...
Rapid adoption of newer antiseizure medications has pushed increases in government spending that outpace the growth of prescriptions themselves....
The increased risks of depression following epilepsy, and vice versa, are sustained over a much more extended time period than previously shown....
“Our study of people with neurologic conditions found that fewer than 20% were being treated with new medications.”
A post hoc analysis shows that the drug works about as well in Lennox-Gastaut syndrome as in patients with pediatric encephalopathies.
Under a provision of the 2010 Affordable Care Act, children enrolled in Medicaid or the Children’s Health Insurance...
Despite strong evidence supporting the clinical importance of surgical evaluation in patients with drug-resistant epilepsy, delays in referrals...
The annual cost of brand-name ASMs rose from $2,800 in 2008 to $10,700 in 2018, while the cost of generic drugs decreased from $800 to $460 during...
“Our findings suggest that people with epilepsy should avoid high CO exposure to reduce potential seizure risk.”
Verbal scores at age 3 were similar among children of mothers with or without epilepsy.